Previous Clinical Trials

Mild to Moderate Alzheimer’s disease

The Memory Disorders Program, located on the campus of Butler Hospital, conducted a clinical research study to determine the efficacy, safety, and tolerability of a new medication for treating mild to moderate Alzheimer’s disease.

Men and women 40 to 85 years of age who are in good health and have been diagnosed with mild to moderate Alzheimer’s disease may be eligible to participate.

Involvement in the study lasts up to 5 months and includes 9 visits to the Memory Disorders Program.

A person who knows you well and is available to provide information about your day-to-day functioning is also required to accompany you to clinic visits.

For more information, please contact the Memory Disorders Program at 401-455-6402.

All inquiries are confidential.